Evidence map›Paper›PMID 33754803›Full record

Trial reportJournal of the American Heart Association2021

Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials.

Michael I Brener, Isaac George, Ioanna Kosmidou, Tamim Nazif, Zixuan Zhang, Jose M Dizon, Hasan Garan, S Chris Malaisrie, Raj Makkar, Michael Mack and 6 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Discovery ofBiology · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Michael I BrenerDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Isaac GeorgeDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Ioanna KosmidouDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Tamim NazifDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Zixuan ZhangCardiovascular Research Foundation New York NY.
Jose M DizonDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Hasan GaranDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
S Chris MalaisrieNorthwestern University Feinberg School of Medicine Chicago IL.
Raj MakkarCedars-Sinai Medical Center Los Angeles CA.
Michael MackBaylor Scott & White Health Plano TX.
Wilson Y SzetoUniversity of Pennsylvania Philadelphia PA.
William F FearonStanford University Stanford CA.
Vinod H ThouraniPiedmont Heart & Vascular Institute Atlanta GA.
Martin B LeonDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Susheel KodaliDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Angelo B BivianoDivision of Cardiology NewYork Presbyterian-Columbia University Medical Center New York NY.
Columbia University Irving Medical Center · USBaylor Scott & White Health · USCardiovascular Research Foundation · USCedars-Sinai Medical Center · USNorthwestern University · USPiedmont Atlanta Hospital · USStanford University · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The impact of atrial fibrillation (AF) in intermediate surgical risk patients with severe aortic stenosis who undergo either transcatheter or surgical aortic valve replacement (AVR) is not well established. Methods and Results Data were assessed in 2663 patients from the PARTNER (Placement of Aortic Transcatheter Valve) 2A or S3i trials. Analyses grouped patients into 3 categories according to their baseline and discharge rhythms (ie, sinus rhythm [SR]/SR, SR/AF, or AF/AF). Among patients with transcatheter AVR (n=1867), 79.2% had SR/SR, 17.6% had AF/AF, and 3.2% had SR/AF. Among patients with surgical AVR (n=796), 71.7% had SR/SR, 14.1% had AF/AF, and 14.2% had SR/AF. Patients with transcatheter AVR in AF at discharge had increased 2-year mortality (SR/AF versus SR/SR; hazard ratio [HR], 2.73; 95% CI, 1.68-4.44;

Indexed as

Aged, 80 and overAortic Valve StenosisAtrial FibrillationElectrocardiographyFemaleHeart RateHumansIncidenceMalePostoperative ComplicationsSurvival RateTranscatheter Aortic Valve ReplacementTreatment OutcomeUnited Statesaortic stenosisatrial fibrillationtranscatheter aortic valve replacement

Identifiers

PMID33754803
PMCPMC8174321
OpenAlexW3138861648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.